Abnormalities in liver functions tests, including transient and self-limiting hypertransaminasemia, cholestatic disease and hepatitis can develop during treatment with anti-TNF-α and, in some cases, they could be severe and life threatening [6,7]. Here, TNF is linked to Hepatitis.